Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chandra has not proven anything. Has not proven he’s not a scam artist. Just waiting for him to clear the BS.
I hope that they restart all ops under Adnexus or Mabtech... OR... Wild idea here, I know... They restart under a company name that doesn't exist yet... I hope under any new entity that CC learns the term "Fiduciary Duty".
Everybody enjoy the Fake Holiday.
You must told Chandra in high regard or one of those that believe a MD takes a great deal of intelligence - just visit a Emergency Room not particularly bright.
If Chandra was so brilliant - why is he involved in a OTC share selling scheme.
I have never been wrong about a OTC scam I have posted about. Because I am not naive and so gullible that I believe I believe all of the company hype.
How is the revenue with Chandra being involved?
Post a link or post your DD to prove that Chandra has delevoped AI for drug discovery - he hasn't applied for a patent - he hasn't published any research in a peer reviewed journal.
The only thing you have are company press release and if you believe that from an OTC company that doesn't report to the SEC - those companies are called Dark because they lack any transparency.
IG
Yep, a certified well-engineered elaborate SCAM
Hmmm, you were the one who was giddy about the big SAGA deal-you were pumping your ass off about.
How could you be so gullible to believe two empty worthless shells are worth $450 Million. LMAO!
I told everyone right from the from the start that the SAGA deal was fake and for pumping purposes only. But you believed it:
"BTW, agree fully with those expecting big news before the late Q3 - early Q4 testing results come in. Patient success cases and new SAGA announcements would carry a lot of weight, and if we've seen anything in CC's history, is that he does like to brag about his successes early on."
You are pumping 247 still attempting to get others to invest so you can dump your shares.
IG
None of the IP has any value. You can leg ride the CC group all you want - but they haven't accomplished anything of value.
Shareholders were played.
And I am not certain what is so difficult to understand that a drug patent is worthless without FDA approved clinical trials.
Do you want them to issue more pumping press releases and take more money from investors?
IG
$14M showing on the Bid now at $.0025! eom
$ENZC After all those NONSENSE Twitter/X Posts from the "Enzolytics Wanna Be" account yesterday , here is the result
First Hour of the Market today 24 Trades for just a little over $ One Thousand Dollars. SHAMEFUL what this has become.
There is a very real possibility that the CCC group may have to abandon Enzolytics, Inc. to advance their IP. I believe that the CCC group has regained control of their IP, but I'm still unclear as to who currently has control of BGEN which I believe has the contract for the exclusive rights to the use of the IP. I believe it is currently Enzolytics, Inc. Yes, I do believe they can leave the original investors behind. At one time I was invested in Marvel at the start of them dominating the movie market. Things were looking good for an investor at that time, until they declared bankruptcy which wiped out the investors of the time.
"I doubt you have verified any of this nonsense."
"Chandra isn't smart enough..."
"Where is your proof..."
SAT, ACT, grade school GPA, middle school GPA, high school GPA, undergrad and/or grad GPA any one of these records I will accept as proof that Chandra isn't smart enough. I am not claiming that he has developed proprietary AI, but to constantly bash him without providing any evidence that he is actually not intelligent is a bad look.
On a separate issue, were you able to find any SPACs that failed to complete a BCA and were delisted from Nasdaq that went on to be approved for listing on the OTC? I have yet to find an example of one and do not believe it is possible even though you continue to bring it up like it is regular procedure for a delisted SPAC to move to the OTC and that SAGA should already be trading on the OTC. If you don't want to provide an example of a specific company, can you at least provide a link to the rules that allow this (or enough keywords that I can attempt to research what you claim to be true that I can verify it for myself)?
You do make valid points at times (which is why I did not block you), but then you wreck your credibility when you bring up things like Adnexus Therapeutics.
COMPARATIVE NOTES FOR TODAY:
Gilead's top contender in the mABS market, once bragged upon and pumped endlessly for investors and their biopharma futures, Magolimab, a top cancer fighting product, took a nose dive this week, showing toxicology and a higher likelihood of death set of issues. All Clinical Stage 1 testing has been put on hold. Stage II indefinitely delayed for now.
This Magrolimab product, was Gilead's leading research and product line to begin a large procession of mABS therapeutics and possibly cures. Now its going nowhere after more testing and analysis has been orderd up to see what's next for Gilead.
I hope Dr. Chandra caught sight of this development, one of the potential partnership suitors just hit a wall with their own top mABS therapeutic candidate. Opportunities....
GLTA
https://www.biospace.com/article/gilead-s-magrolimab-ineffective-linked-to-increase-risk-of-death-in-mds-patients/?utm_campaign=Newsletter%20%7C%20GenePool&utm_medium=email&_hsenc=p2ANqtz-8UI3j5puZ2dGw19iNTUUC-hYAA5yf9BLiwm6iOMb9mszDCVjhTUK5EAuohii6iLfj-9OitCLSyYpmmDMLvlzgsXRevSQ&_hsmi=311924366&utm_content=311924366&utm_source=hs_email
To me it does not appear that any of them are running for cover. Back when the GLD vs. SAGA case first started had someone told me Kelli was nervous and was possibly frightened by the potential outcome of the court case, I would have agreed based on what she was filing with the court. Since then (almost immediately after her initial statements), I have done my research and learned what type of person she is. The people involved here do not appear to care about legal issues and are doing whatever they want to do knowing that any issue will be tied up in a court case for a period of time. Is there a link to the current case of GLD Sponsor vs. BN Holdings Trust? The one I'm attaching below was claimed to have already been decided on (Decided on September 12, 2023).
"GLD Sponsor Member, LLC, Plaintiff,
against
BN Holdings Trust and Kelli D. Austin, Defendants."
https://www.nycourts.gov/REPORTER/3dseries/2023/2023_51077.htm
His old "rugged PC and Tablet business" he folded into the ground was almost as PINK as one could get, but he started out with better financing initially. He's born for the OTC racket. Robutomed did nothing but house old documents. Sharabura oversaw that... lol.... he's probably running origami or macramé classes out of a garage right now.
LMAO, BGEN has not pumped or announced anything since Summer of last year.
Poor try, already common knowledge.
Docset.. Noted, LOL, but you MAY want to recant that. Sharabura came along from Billy Ray , he had NO KNOWLEDGE and STILL DOES NOT how OTC Land works or would be around for another OTC SYMBOL , other than to have a PUPPET.
Already known , but thanks anyway
I doubt you have verified any of this nonsense.
"The Three C's have many avenues to move on with their Proprietary AI and Intellectual Property"
Chandra isn't smart enough to have developed any Proprietary AI and there isn't any IP that has commercial value.
Where is your proof the ENZC have developed any type of AI? Where is the research - did they publish it in a peer reviewed journal? Did they apply for a patent.
"It's a well-known fact that a vast majority of patents are worthless. Around 97% of all patents never recoup the cost of filing them. That figure has been floating around for years. There’s other compelling evidence.
On his website Patently-O, Dennis Crouch, the co-director of the Center for Intellectual Property & Entrepreneurship at the University of Missouri School of Law, points out that about 50% of patents expire prematurely because their owners decline to pay the required maintenance fees."
The ENZC clowns have never monetized any IP.
IG
It could mean that, it could also mean that other legal liabilities may leave ENZC up for the grabbing, and they're about to be in position.
No doubt. I'm still giving 20:1 odds that Sharabura is the first one to disappear to some other pink operation.
GLTA
ENZC isn't registered as a Business Entity in Texas:
"Right to Transact Business in Texas: FORFEITED"
"Effective SOS Registration Date: Not Registered"
ENZC claims to be domiciled in Texas but they can't conduct any business.
"BIOGENYSIS, INC
Right to Transact Business in Texas: FRANCHISE TAX INVOLUNTARILY ENDED"
"Effective SOS Registration Date: 12/01/2020"
ENZC is a pumping press release company.
IG
Well, there are many "Theories" out there and that is one of them , Yes.
--
TIME will tell, However for sure there will be "Something" that happens .
--
a. If ENZC continues as is , what is their support backing, appears to be Little to None.
b. Why would anyone want to take over ENZC , IF AT ANYTIME and past History would come along with it. Doubt it. Will be New is another
c. New and Improved ENZC, that has no tie to any past History , Perhaps that is BGEN, is one .
d. SEC comes into play with any investigation, is one , Not sure if SEC has time for a NON REPORTING SEC Symbol, Lets See. Is another
e. A Texas Ranger knocks on the doors to Harry Z , Barry K and Kelli Austin, after all it is the Lone Star State. is another
f. Just falls into OTC TWILIGHT ZONE like so many other Symbols have done in the past. Perhaps
g. Disgrunted ENZC shares holders in Texas "Egg" the houses of Harry Z , Barry K and Kelli A , plus puts sugar in their gas tanks of cars, or Tee Pee's Steve Sharabura's House in Atlanta. Very Possible.
--
Could Chandra and Crotopia do something different , of course they could .
--
Lets See.
What do you mean by:
The Three C's have many avenues to move on with their Proprietary AI and Intellectual Property
Do you mean they can move on somewhere else and leave “us” the original investors behind??
$ENZC Does it not appear that with the recent postings of the ENZC twitter nonsense , that the Four Failures Barry K , Harry Z , Kelli A and Steve S are running for cover in so many areas. The Three C's have many avenues to move on with their Proprietary AI and Intellecutal Property . Lets See. $ENZC GLD moving forward in Texas with their attempt to depose Kelli Austin. https://t.co/CvysKSiwC6 pic.twitter.com/7ZUGLYSunI
--
Good point. Not only that, but the notes are convertible at some undisclosed rate. Due in less than 2 weeks. It was not a public offering and not a bank loan. Who are these investors? In the past, some Bulgarians, apparently familiar with past ITV-1 trials, have provided cash through preferred stock purchases or partnership agreements. JMHO.
If they did need the money, the convertible feature may have been necessary. However, if ENZC wasn't in dire need of the money on short notice, it tends to look (to me) like a favor and possibly a backdoor way to award an excessive number of shares to somebody if the conversion rate is anything other than the current price of the stock at the time of the conversion. JMHO.
ENZC hasn't filed a Form 10 to become a SEC reporter.
ENZC is a dark company and that means it lacks transparency and doesn't file anything to the SEC.
If a OTC company doesn't report to the SEC - RUN! Because it is guaranteed to be a scam.
The SAGA deal is dead - there isn't anything to discuss about SAGA after being delisted from Nasdaq most companies start trading on the OTC - but SAGA isn't trading anywhere.
But these shells are passed around between scammers - so someone might takeover and has created AI that predicts the price of crypto.
IG
Definitely strange. If I worked for Enzolytics, and had an SEC auditor and an IRS tax guy come in to review the books, I'd not want to be anywhere near that building.
Unless I'm reading it incorrectly, the "two investors" each made a loan for $125,055 for a total of $250,110 in May. Then in June "two investors" (may or may not be the same ones from May) each made a loan for $375,000 for a total of $750,000. These loans were made to Enzolytics after the announcement of the SAGA deal. It's odd that they needed to take a $750,000 loan to fund BioGenysis and Virogenetics just six weeks after taking a $250,110 loan for the same purpose. I also find it odd that the day after taking the $750,000 loan the purchase price of the subs by SAGA changes from $250,000,000 to $450,000,000.
On May 12, 2023 and May 15, 2023, two investors loaned $125,055 each at 10% interest due May 12, 2024
and May 15, 2024 and June 15, 2024 to fund BioGenysis, Inc. and Virogentics, Inc.
On June 28, 2023, two investors loaned $375,000 each at 10% interest due June 28, 2024 and June 28, 2024
to fund BioGenysis, Inc. and Virogentics, Inc
Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, and Sagaliam Acquisition Corp. (NASDAQ:SAGA) ("Sagaliam") (together the "Parties") announced today they have agreed to an amendment to the executed non-binding term sheet for the sale of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of the Company, amending the combined purchase price to $450,000,000.00. In addition, the Parties have agreed to a Make Whole calculation six months after close to ensure the value to be received by ENZC. The Parties will now focus on completing the business combination agreement as soon as possible.
Yep, 2 separate birds with no mating potential.
You may have missed the post I was responding to that was attempting to make it appear that Adnexus Therapeutics was the same as Adnexus Technologies.
Sorry but Patents Assigned to Adnexus Therapeutics, Inc. - are patent applications from 2007.
Adnexus doesn't own any active patents.
So what are they protecting.
IG
I hope they get ENZC back and get clear of all of these legal case hindrances.
It's business that's too messy to ever run smoothly at this point.
One thing is certain, you don't go out on your last legs in court, if you don't have something that works.
Too bad it's not the old west, where we could just find them in a saloon fight and shoot them for cheating at cards. (Zhabilov & Co.)
The term "Two Investors" sounds pretty loose there. But the $375K plus the $20K and $10K sounds like the $400K plus that Chandra said Charles put in personally to keep the research and lab testing going.
Can't be certain, but it's as good a guess as any. The 2 investors being Charles and Chandra (?) May have been their additional share stake as well, in getting voting control back.
Yes, all speculation.
Adnexus Therapeutics has nothing to do with Adnexus Technologies from my understanding. Am I missing something?
Agreed about the $20K fee SAGA put up in the NASDAQ case. I thought you were referring to the GLD case.
You asked:
If SAGA only had $19 in cash, who put up the $20,000 and why?
Cash Acquired in Acquisition 537,443
Current assets:
Cash and cash equivalents $ 559,554
Cash flows from financing activities
Proceeds received from the issuances of notes payable from investors 559,587 -
On May 12, 2023 and May 15, 2023, two investors loaned $125,055 each at 10% interest due May 12, 2024
and May 15, 2024 and June 15, 2024 to fund BioGenysis, Inc. and Virogentics, Inc.
On June 28, 2023, two investors loaned $375,000 each at 10% interest due June 28, 2024 and June 28, 2024
to fund BioGenysis, Inc. and Virogentics, Inc
Convertible promissory note, due May 12, 2024, interest at 10% per anum, unsecured Convertible 125,055
promissory note, due May 15, 2024, interest at 10% per anum. Unsecured 125,055
Convertible promissory note, due June 28, 2024, interest at 10% per anum, unsecured 375,000
Convertible promissory note, due June 28, 2024, interest at 10% per anum. unsecured 375,000
Who is the current "Sponsor Member LLC (for the SPAC)"? How can a SPAC that is delisted from Nasdaq be allowed to list on the OTC? Do you have any examples of SPACs that failed to complete a BCA, had numerous violations causing them to be delisted from Nasdaq, and then went on to be listed on any tier of the OTC? I will agree with you that I also believe the SAGA deal is dead, although we will have to wait for the court's decision.
You do realize that Adnexus Therapeutics has no association with Enzolytics, Inc., or its current/former leadership, correct? Why not bring up patent applications from Bristol-Myers Squibb, Pfizer, Johnson and Johnson, etc.? Bristol-Myers Squibb acquired Adnexus Therapeutics in 2007. It would only be logical that after the acquisition the patents would be applied for via the current owner (Bristol-Myers Squibb). I don't see how this relates to Enzolytics, Inc.
Sorry but Patents Assigned to Adnexus Therapeutics, Inc. - are patent applications from 2007.
Adnexus doesn't own any active patents.
So what are they protecting.
IG
Which brokers won't deal with Zhabilov?
"There are certain brokerages that won’t deal with him, as far as converting restricted shares. They “know of him “."
That isn't proof of anything but pinkyland wishful thinking.
There isn't any brokers that would release that information.
IG
It wasn't just GLD but also Sponsor Member LLC (for the SPAC).
It doesn't matter as SAGA has been delisted from Nasdaq and they still aren't listed on the OTC.
The SAGA deal is dead just as it was when first announced.
IG
The $100,000 is the bond the Judge ordered GLD to put up in the court case. I believe it was a result of requesting a TRO to prevent SAGA from holding a shareholder vote. I don't believe it was negotiated down, but I do believe GLD will be able to have that money returned to them. I believe the GLD case is about a lot more than $500,000. Look at the number of shares GLD owns. I don't know which party wrote the schedule, but it had to be agreed to by both parties. To have a fair trial there needs to be time for things like evidence discovery, witness depositions, expert testimony, etc. The Judge did have to approve the schedule, see courtlistener Item 49 (Item 48 is the proposed order). If the Judge or any of parties involved had a problem with any of the dates they would have modified the proposed order. GLD has nothing to gain by having this case drag on.
The other lawsuit about the "termination fee" due to the failed Saudi deal is a result of SAGA's own Articles of Incorporation. I am not following that case.
What I was referring to is the non-refundable hearing fee of $20,000 to appeal their Nasdaq delisting. This was a non-refundable fee not a bond. SAGA had to have known that they had zero chance of winning an appeal and remaining listed on Nasdaq. If SAGA only had $19 in cash, who put up the $20,000 and why?
Separately, on October 24, 2023, Nasdaq notified the Company that is does not comply with the minimum 400 total holders requirement, as required by Listing Rule 5450(a)(2). Additionally, on August 23, 2023, Nasdaq notified the Company that it did not comply with Listing Rule 5250(c) due to its failure to timely file its Form 10-Q for the period ended June 30, 2023. The Company has also not filed its Form 10-Q for the period ended September 30, 2023. These failures to timely file periodic reports and maintain a minimum of 400 total holders each serve as additional and separate basis for delisting.
Finally, under Listing Rules 5101 and IM-5101-1, Nasdaq may “suspend or delist particular securities based on any event, condition, or circumstance that exists or occurs that makes initial or continued listing of the securities on Nasdaq inadvisable or unwarranted in the opinion of Nasdaq.” In light of the Company’s disregard for Nasdaq rules, as evidenced by its multiple violations of Nasdaq’s shareholder approval rules, ongoing failure to disclose material information and timely file periodic reports, and failure to comply with Nasdaq’s SPAC rule, Nasdaq has determined that the continued listing of the Company’s securities on Nasdaq is inadvisable and believes the delisting is appropriate to protect investors and the public interest.
In that regard, unless the Company requests an appeal of this determination as described below, trading of the Company’s securities will be suspended at the opening of business on December 14, 2023, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market.
The Company may appeal Staff’s determination to a Hearings Panel, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Hearings are typically scheduled to occur approximately 30-45 days after the date of the hearing request. A request for a hearing regarding a delinquent filing will stay the suspension of the Company’s securities only for a period of 15 days from the date of the request. When the Company requests a hearing, it may also request a stay of the suspension, pending the hearing. The request should include an explanation of why an extended stay is appropriate. A Panel will review the request for an extended stay and notify the Company of its conclusion as soon as is practicable but in any event no later than 15 calendar days following the deadline to request the hearing.
Requests for a hearing and for an extended stay should be submitted electronically through our Listing Center, and must be received no later than 4:00 Eastern Time on December 12, 2023. Please note that if a request is not received by that date and time, trading in the Company’s shares will be suspended on the second business day following the deadline. The request for a hearing should be accompanied by confirmation of a wire transfer of the fee for a hearing. The fee for a hearing is $20,000. Please send your non-refundable hearing fee in accordance with instructions on the attached Hearing Fee Payment Form.
It was GLD that put up the bond. The judge set it at $100,000 and gave GLD 3 days to put up or shut up (Item 22 at CL, link below), but I think it was negotiated down somewhat and may have been the $20,000 you quoted. GLD had already gotten about $500,000 (roughly half) on their sale of the Sponsor stock to Austin, and she was delinquent on the other half at the time the suit was filed. (GLD has a judgment for the balance due now. Apparently, she didn't show up for the hearing.) JMHO.
Suing to terminate SAGA seems counterproductive to GLD's collecting the other half, but the fact that GLD was willing to put up non-refundable money to bring a suit to shut SAGA down is what surprised me. Then, they even wrote the trial schedule for the judge, stretching it out to late 2025. If the judge didn't dictate that schedule, there's something very strange about GLD's motivations. Now SAGA is hit with a $2 million legal fee lawsuit, which most likely relates to fees for the failed Saudi deal, which was started and ended while GLD was the SAGA Sponsor. Related to GLD motivations?? JMHO.
https://www.courtlistener.com/docket/67985445/gld-partners-lp-v-sagaliam-acquisition-corp/
Item number 24:
Nov 22, 2023
NOTICE of Filing of an Injunction Bond, by GLD Partners, L.P., GLD Sponsor Member LLC. (Bellew, Sean) Modified on 11/22/2023 (nms). (Entered: 11/22/2023)
Flicker1, Good information to know… thanks.
There are certain brokerages that won’t deal with him, as far as converting restricted shares. They “know of him “.
Unless Zhabilov decides to just sign off on everything, this will take a while to sort out. He will likely thwart every move to do so until he is paid in shares or other compensation, or the OTC bans him.
If I remember correctly both dealt with debt incurred prior to the BioClonetics merger. I did not follow them as I did not feel at the time they would have a significant impact on the share price, and I still don't. The case I think will have an impact on Enzolytics, Inc. is the GLD vs SAGA case. Between the SEC filings, Kelli's court filings/deposition, Nasdaq removal, Enzolytics 11/20/23 PR, etc. I'm surprised the case is still continuing. To be fair I was also surprised (actually shocked) that SAGA was willing to put up five figures (I believe it was only $20,000 but would have to check) non refundable to appeal their Nasdaq delisting. A SPAC that claimed to have $19 in cash was willing to spend five figures on an appeal they should have knew they would lose is crazy. They had done nothing to correct the deficiencies that Nasdaq pointed out and should have known that they would lose their appeal. I believe they were just buying time with their delisting appeal challenge. Merganthaler may have a case, and therefore an impact on Enzolytics, Inc., but I only have access to courtlistener so I can't see all the information. From what I have seen of that case it is questionable as to who actually owns Enzolytics, Inc., but like I said I don't have access to all the information.
enzc what pos look
https://stockcharts.com/freecharts/gallery.html?ENZC
https://www.otcmarkets.com/stock/ENZC/security
rs coming??? or what??? glad i sold yrs ago !!
is it safe to buy back here?
Weren't both of these cases identical in that they were contesting the 251g reorg which made their debt convertible into Robusto's stock (which is old ENZC prior to the merger with BioClonetics) instead of new ENZC's stock? I think those debts are relatively small and were incurred prior to Harry buying the company back when its business was motor oil. JMHO.
That is what I was thinking too. What a mess they have created over the past year. We all need luck at this point with Enzolytics.
It looks like that case has been combined with another case. There were a number of filings that occurred in the Cimarron Capital case (the one I believe the Kona case was combined with) yesterday.
https://www.courtlistener.com/docket/60989844/enzolytics-inc-v-kona-concepts-inc/
https://www.courtlistener.com/docket/60989842/enzolytics-inc-v-cimarron-capital-ltd/
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."___
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |